Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HLA complex group 4 pseudogene (ENSG00000271581) is a non-coding DNA segment located in the human major histocompatibility complex (MHC)/HLA locus on chromosome 6. It does not encode a protein or exert a known biological function and is considered a nonfunctional genomic remnant—possibly a byproduct of evolutionary gene duplication within the highly polymorphic HLA region. While some HLA pseudogenes can produce non-coding RNAs, there is no evidence this particular pseudogene acts as a functional regulatory RNA. It does not participate in antigen presentation or immune signaling, and it is not used as a diagnostic or therapeutic marker. This is not a conventional molecular target—it is classified as a pseudogene in the HLA region and should not be annotated as a receptor, enzyme, transporter, or direct drug target.
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HLA complex group 4 pseudogene (HCG4P).